Azitra prices $5M public offering of 16.7M shares at $0.30/share

Azitra, Inc.

Pricing of 16,667,000 shares at $0.30/share for gross proceeds of ~$5M.
Underwriters granted 45-day over-allotment option to purchase up to 2.5M additional shares.
Net proceeds to fund clinical trials, R&D, manufacturing, and working capital.
Offering expected to close Feb 16, 2024.
Lock-up agreements for directors and officers until Aug 13, 2024.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Azitra, Inc. entered into Underwriting Agreement with ThinkEquity LLC valued at $5 million (effective 2024-02-13).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity LLC
Value: $5 million
Effective: 2024-02-13

Exact text from the filing

On February 13, 2024, Azitra, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with ThinkEquity LLC (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 16,667,000 shares (“Shares”) of common stock of the Company (“Common Stock”).

View on SEC.gov

119 material agreements filed in the last 30 days. Browse all material agreements →

Azitra, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-006365

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.